Out Of The Blocks, January 2015
Executive Summary
Snapshots of these recently formed companies: Aspen Park Pharmaceuticals, CeMeT, Enlitic, Prima-Temp, and TC BioPharm.
Aspen Park Pharmaceuticals Inc.
944 Park Avenue
New York, NY 10028
Phone: (901) 581-5872
Email: [email protected]
Management: Mitchell Steiner, MD, Co-founder, President & CEO; Harry Fisch, MD, Co-founder, Chairman & CSO
Company Launched: October 2014
Financing To Date: Undisclosed Series A
Investors: Undisclosed
Partners/Alliances: NA
Industry Segment: Men’s Health
Business: Aspen will develop therapeutics for a variety of men’s health conditions including male secondary hypogonadism, prostate cancer, and sexual dysfunction. It’s in late-stage trials of a novel form of clomiphene citrate to treat men with hypogonadism, and also has an OTC product, Preboost, a topical benzocaine wipe to treat premature ejaculation.
[CeMeT GMBH]
Paul-Ehrlich-Strasse 23
72076 Tübingen, Germany
Phone: +49 7071 565 44 460
Email: [email protected]
Web Site: www.cemet-gmbh.de
Management: Dirk Biskup, PhD, Managing Director; Isabell Flade, Director; Ingo Autenrieth, PhD, Daniel Huson, PhD, and Detlefn Weigeln, PhD, Scientific Founders & Advisors
Company Launched: July 2014
Financing To Date: Undisclosed
Investors: Undisclosed
Partners/Alliances: CeGat GMBH; Max-Planck Institute; University of Tübingen; University Hospital of Tübingen
Industry Segment: Metagenomics
Business: Founded by genetic diagnostics company CeGaT GMBH and three Tubingen-area academics, CeMeT’s mission is to analyze the genetic information of microorganisms in the human body and advance development of diagnostics and treatments. The company offers its metagenome analysis services to doctors and scientists, as well as private clients.
[Enlitic Inc.]
1355 Market Street
Suite 488 San Francisco, CA 94103
Email:[email protected]
Web Site: www.enlitic.com
Management: Jeremy Howard, Founder & CEO; Ahna Girshick, PhD, Choon Hui Teo, PhD, and John Zedlewski, Senior Data Scientists; Rodney Sappington, PhD, Senior Clinical Data Scientist
Company Launched: July 2014
Financing To Date: $2 million seed funding
Investors: Amplify; Data Collective
Partners/Alliances: NA
Industry Segment: Big Data
Business: Enlitic will use deep learning to mine and process data from medical images, giving doctors a tool to discover subtle patterns that characterize disease profiles and guide their diagnoses.
2820 Wilderness Place
Suite C
Boulder, Colorado 80301
Email: [email protected]
Web Site: www.prima-temp.com
Management: Lauren Costantini, PhD, CEO; Wade Webster, MD, Co-founder & CMO; Rich Pollack, Co-founder & CTO; Don Kirkpatrick, Chairman
Company Launched: September 2013
Financing To Date: Undisclosed
Investors: Undisclosed
Partners/Alliances: NA
Industry Segment: Wearable Sensors
Business: Prima-Temp’s self-inserted cervical ring contains a sensor that tracks body temperature, helping women identify times of peak fertility.
Pentlands Science Park
Bush Loan
Edinburgh, EH26 0PZ, Scotland
Phone: +44 131 445 6197
Email: [email protected]
Web Site: www.tcbiopharm.com
Management: Michael Leek, PhD, CEO; Artin Moussavi, PhD, Executive Chairman; Angela Scott, Operations Director; Keith Gillon, PhD, Director of Clinical & Regulatory Affairs; David Gallagher, Director of Commercial Affairs
Company Launched: July 2013
Financing To Date: Undisclosed
Investors: Medinet; Other undisclosed investors
Partners/Alliances: Medinet; Sistemic
Industry Segment: Regenerative Medicine
Business: TC BioPharm is developing an autologous anti-cancer immunotherapy that involves expansion of naturally occurring, cancer-killing T cells over several weeks, formulating a treatment for a wide variety of different tumor types. The start-up recently opened a clinical manufacturing facility in Glasgow.